Ya‐Ting Hsu

1.1k total citations
53 papers, 768 citations indexed

About

Ya‐Ting Hsu is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Ya‐Ting Hsu has authored 53 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 10 papers in Hematology. Recurrent topics in Ya‐Ting Hsu's work include Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Viral-associated cancers and disorders (4 papers). Ya‐Ting Hsu is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Viral-associated cancers and disorders (4 papers). Ya‐Ting Hsu collaborates with scholars based in Taiwan, United States and China. Ya‐Ting Hsu's co-authors include Michel Baudry, Xiaoning Bi, Qian Qin, Hussam Jourdi, Miou Zhou, Tsai‐Yun Chen, Chien‐Chun Li, Chong‐Kuei Lii, Che‐Yi Chao and Chia‐Yang Lu and has published in prestigious journals such as Journal of Neuroscience, Blood and PLoS ONE.

In The Last Decade

Ya‐Ting Hsu

50 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ya‐Ting Hsu Taiwan 14 255 159 156 106 90 53 768
Mao‐Liang Chen Taiwan 18 388 1.5× 133 0.8× 83 0.5× 97 0.9× 51 0.6× 56 918
Kai Yue China 18 432 1.7× 127 0.8× 177 1.1× 179 1.7× 67 0.7× 56 1.0k
M. Idalia Cruz United States 15 410 1.6× 111 0.7× 124 0.8× 103 1.0× 37 0.4× 24 994
Yongsheng Jiang China 17 325 1.3× 86 0.5× 135 0.9× 129 1.2× 36 0.4× 53 828
Haiying Chen China 12 343 1.3× 266 1.7× 79 0.5× 86 0.8× 52 0.6× 36 797
Neha Singh India 13 343 1.3× 94 0.6× 88 0.6× 49 0.5× 41 0.5× 36 675
Wei‐Bing Xie China 20 509 2.0× 204 1.3× 105 0.7× 134 1.3× 112 1.2× 41 1.0k

Countries citing papers authored by Ya‐Ting Hsu

Since Specialization
Citations

This map shows the geographic impact of Ya‐Ting Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Ting Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Ting Hsu more than expected).

Fields of papers citing papers by Ya‐Ting Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Ting Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Ting Hsu. The network helps show where Ya‐Ting Hsu may publish in the future.

Co-authorship network of co-authors of Ya‐Ting Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Ting Hsu. A scholar is included among the top collaborators of Ya‐Ting Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Ting Hsu. Ya‐Ting Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Ya‐Ting, Pei‐Ying Wu, Yu‐Min Yeh, et al.. (2024). Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition. Journal of Experimental & Clinical Cancer Research. 43(1). 65–65. 6 indexed citations
2.
Hsu, Ya‐Ting, et al.. (2024). Gaucher-like crystal-storing histiocytosis associated with kappa chain myeloma: A case report with next generation sequencing study. Pathology - Research and Practice. 263. 155609–155609. 1 indexed citations
4.
Hsu, Ya‐Ting & Chi‐Hau Chen. (2024). Progression of fertility-sparing treatment for atypical endometrial hyperplasia in a woman with lynch syndrome: a case report and review of the literature. Frontiers in Oncology. 14. 1422006–1422006. 2 indexed citations
5.
Hsu, Ya‐Ting, Li‐Hsien Chen, Shih‐Kai Chu, et al.. (2023). Electrical Sympathetic Neuromodulation Protects Bone Marrow Niche and Drives Hematopoietic Regeneration during Chemotherapy. Small Methods. 7(6). e2201300–e2201300. 6 indexed citations
6.
Hsu, Ya‐Ting, et al.. (2023). Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report. Vaccines. 11(6). 1115–1115. 6 indexed citations
7.
Hsu, Ya‐Ting, et al.. (2023). Multiple myeloma presenting with hepatic light chain deposition. Blood. 141(19). 2402–2402.
8.
Chung, Wei‐Pang, et al.. (2021). The prognosis of early-stage breast cancer in extremely young female patients. Medicine. 100(1). e24076–e24076. 5 indexed citations
9.
Chen, Yaping, et al.. (2021). False-negative frozen section of sentinel nodes in early breast cancer (cT1-2N0) patients. World Journal of Surgical Oncology. 19(1). 183–183. 3 indexed citations
10.
Ho, Hsing-Ying, Vincent Chin‐Hung Chen, Bor‐Show Tzang, et al.. (2021). Circulating cytokines as predictors of depression in patients with breast cancer. Journal of Psychiatric Research. 136. 306–311. 13 indexed citations
11.
Chung, Wei‐Pang, Ya‐Ting Hsu, Ching‐Hsia Hung, et al.. (2021). Real-time exercise reduces impaired cardiac function in breast cancer patients undergoing chemotherapy: A randomized controlled trial. Annals of Physical and Rehabilitation Medicine. 65(2). 101485–101485. 36 indexed citations
12.
Huang, Wei‐Li, Yaping Chen, Yau‐Lin Tseng, et al.. (2021). Pure Red Cell Aplasia and Other Haematological Diseases Associated With Thymoma: A Case Series and Systematic Review. Frontiers in Medicine. 8. 759914–759914. 6 indexed citations
13.
Hsu, Ya‐Ting & Kung‐Chao Chang. (2017). Breast cancer with extensive bone metastasis mimicking myeloma. Clinical Case Reports. 5(2). 203–204. 1 indexed citations
14.
Hsu, Ya‐Ting, Paweł A. Osmulski, Yao Wang, et al.. (2016). EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition. Cancer Research. 76(21). 6171–6182. 40 indexed citations
15.
Huang, Rui, Po‐Hsuan Su, Yu-Ping Liao, et al.. (2016). Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings. Clinical Cancer Research. 23(1). 263–272. 65 indexed citations
16.
Jadhav, Rohit R., Ya‐Ting Hsu, Joseph K. Liu, et al.. (2016). Methyl-binding DNA capture Sequencing for Patient Tissues. Journal of Visualized Experiments. 1 indexed citations
17.
Hsu, Ya‐Ting, Fei Gu, Yi-Wen Huang, et al.. (2013). Promoter Hypomethylation of EpCAM-Regulated Bone Morphogenetic Protein Gene Family in Recurrent Endometrial Cancer. Clinical Cancer Research. 19(22). 6272–6285. 36 indexed citations
18.
Huang, Tze‐Ta, Cara B. Gonzales, Fei Gu, et al.. (2013). Epigenetic deregulation of the anaplastic lymphoma kinase gene modulates mesenchymal characteristics of oral squamous cell carcinomas. Carcinogenesis. 34(8). 1717–1727. 17 indexed citations
19.
Chao, Che‐Yi, Chong‐Kuei Lii, Ya‐Ting Hsu, et al.. (2013). Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells. Carcinogenesis. 34(8). 1843–1851. 63 indexed citations
20.
Jourdi, Hussam, Ya‐Ting Hsu, Miou Zhou, et al.. (2009). Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA Translation. Journal of Neuroscience. 29(27). 8688–8697. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026